ImmunityBio Stock Soars 11% as Anktiva Momentum and FDA Catalyst Hopes Fuel Rally in Soon-Shiong's Biotech
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
The ImmunityBio shares closed the session on Wednesday 30 September at 9.44 dollars, an increase of 6.91% compared to the previous closing of 8.83 dollars. The IBRX title touched a maximum intraday of 10.09 dollars, exceeding for the first time since March the psychological threshold of 10 dollars. It is a movement that changes the [...]
ImmunityBio stock surges over 10% to $9.735 as daily trend turns bullish
ImmunityBio stock surged 10.25% on Wednesday, trading at $9.735 as of 14:04 ET. Volume reached 1,030,971 shares. The rally pushed shares to recent intraday highs without an accompanying news catalyst. The daily chart confirms the bullish backdrop. IBRX - daily chart with candlesticks, EMA20/EMA50...
ImmunityBio Stock Soars 11% as Anktiva Momentum and FDA Catalyst Hopes Fuel Rally in Soon-Shiong's Biotech
ImmunityBio shares rose more than 11% as investors weighed accelerating Anktiva sales, international expansion, regulatory milestones and the FDA's planned January 2027 decision on broader use.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
